23. SYSTEMATIC REVIEW OF THE COST - EFFECTIVENESS OF PEMBROLIZUMAB IN RECURRENT OR METASTATIC CERVICAL CANCER. YHCĐ [Internet]. 2025 Aug. 22 [cited 2026 Sept. 9];66(CĐ8-NCKH). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/2569